Thiazolidinediones/insulin use and cancer risk: insights from the recent meta-analyses

Diabetes Metab. 2013 Feb;39(1):3-5. doi: 10.1016/j.diabet.2013.01.001. Epub 2013 Feb 9.

Author

D Simon¹

Affiliation

¹ Service de Diabétologie, Hôpital de la Pitié-Salpêtrière, AP-HP, 83, boulevard de l'Hôpital, 75013 Paris, France. domique.simon@psl.aphp.fr

PMID: 23402842
DOI: 10.1016/j.diabet.2013.01.001

No abstract available

Publication types

Comment

MeSH terms

Diabetes Mellitus, Type 2 / drug therapy*
Diabetes Mellitus, Type 2 / epidemiology*
Humans
Hypoglycemic Agents / administration & dosage*
Insulin / administration & dosage*
Neoplasms / epidemiology*
Neoplasms / prevention & control*
Thiazolidinediones / administration & dosage*

Substances

Hypoglycemic Agents
Insulin
Thiazolidinediones